01/01/1982 - "ASTA (antistaphylolysin titre) appeared to have diagnostic value in continuing hidden staphylococcal infection. "
01/01/1976 - "Of 55 patients with staphylococcal infection only 25 had a positive antistaphylolysin titer. "
04/29/1972 - "[Contribution of antistaphylolysin determination to the diagnosis of osteoarticular staphylococcal infections]."
06/01/1966 - "[Antistaphylolysin test (ASTA) in the diagnosis of staphylococcal infections]."
01/01/1966 - "The antistaphylolysin titers in the sera of patients suspected of having diseases other than staphylococcal infection."
05/26/1956 - "[Antistaphylolysin reaction in staphylococcic infections in children]."
01/01/1951 - "Antistaphylolysin titres (Asta) in normal and pathological sera, with especial reference to gynecological infections."
01/31/1963 - "[Antistaphylolysin and antistreptolysin titers in the diagnosis of rheumatic infection]."
01/01/1955 - "Anticolihemolysin (ACL) antistaphylolysin (ASTA) and antistreptolysin (AST) reactions in urologic infections."
11/01/1997 - "To analyse which rheumatic syndromes are associated with serological evidence of recent Staphylococcus aureus infection, we studied retrospectively 44 adult patients, gathered between 1979-1990, having an acute arthritis syndrome or an exacerbation in their chronic rheumatic disease and simultaneously a high antistaphylolysin (ASTA > 4,0) and/or high teichoic acid antibody titre (TAA > 8). "
10/01/1969 - "[An antistaphylolysin alpha determination in osteomyelitis of the jaw]."
01/01/1960 - "[Antistaphylolysin titer, erythrosedimentation rate, blood protein picture and the antibiogram in chronic osteomyelitis]."
11/01/1959 - "[On the behavior of the "antistaphylolysin" titer in osteomyelitis and in other morbose processes with staphylococcal etiology]."
09/01/1958 - "[Behavior of the antistaphylolysin titer during osteomyelitis in children]."
01/01/1982 - "Teichoic acid antibodies (TAA), measured by gel diffusion, and antistaphylolysin (ASa) values were determined in 46 osteomyelitis patients and 200 healthy controls. "
|1.||Antistreptolysin (Antistreptolysin O)
|3.||Intravenous Immunoglobulins (IVIG)